Sodium Methoxide → HCID 178516780、化合物
反応式
C[O-].[Na+].NC[C:6]([C:8]1[N:9]=[CH:10][N:11]([C@@H:18]2[O:23][C@H:22]([CH2:24][OH:25])[C@@H:20]([OH:21])[C@H:19]2[F:26])[C:12]=1[N:13]=[CH:14][N:15](C)[CH3:16])=[O:7]>CO>[F:26][C@@H:19]1[C@H:20]([OH:21])[C@@H:22]([CH2:24][OH:25])[O:23][C@H:18]1[N:11]1[C:12]2[N:13]=[CH:14][NH:15][CH2:16][C:6](=[O:7])[C:8]=2[N:9]=[CH:10]1参加物
4
実験手順
In step 18, compound (24) is dissolved in methanol and treated with a methanolic solution of sodium methylate at room temperature to effect the ring-formation of the substituents on the imidazole ring of compound (24). Thus, 3-(2-deoxy-2-fluoro-β-D-ribofuranosyl)-6,7-dihydroimidazo-[4,5-d] [1,3]diazepin-8(3H)-one [compound (25)] is produced.
出典と根拠
- ORDレコード
- ord-d6e5e195ec6d4d1cae489c8c5d4439a3
- 出典データセット
- uspto-grants-1999_03
- 特許番号
- US05886167
反応ノート
読み込み中…